Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

SEC Filings

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQLPCN
FormDescriptionDateFormat
S-1/AAmended Registration statement for face-amount certificate companiesDec 29, 2011Open Amended Registration statement for face-amount certificate companies in HTML.Open Amended Registration statement for face-amount certificate companies in DOC file.Open Amended Registration statement for face-amount certificate companies in PDF file.Open Amended Registration statement for face-amount certificate companies in XLS file.
UPLOADCorrespondence from the SEC to the FilerDec 27, 2011Open Correspondence from the SEC to the Filer in HTML.Open Correspondence from the SEC to the Filer in DOC file.Open Correspondence from the SEC to the Filer in PDF file.Open Correspondence from the SEC to the Filer in XLS file.
S-1Registration statement for face-amount certificate companiesNov 30, 2011Open Registration statement for face-amount certificate companies in HTML.Open Registration statement for face-amount certificate companies in DOC file.Open Registration statement for face-amount certificate companies in PDF file.Open Registration statement for face-amount certificate companies in XLS file.